Start Treatment & Recovery Centers
- World rank, all time
- #24,905 of 42,892
- Rank in United States
- #5,345 of 8,685
- Research works
- 197 ▲ 26% vs 2013–17
- Citations
- 3.6k 18.1 per fractional work
- Top-10% rate
- 13.1% record average 16.5%
- Open access
- 31% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Psychology, 4.6×. Every wedge is a field page.
- Psychology 4.6×
- Immunology and Microbiology 3.1×
- Medicine 2.7×
- Biochemistry, Genetics and Molecular Biology 2.3×
- Neuroscience 1.6×
- Nursing 1.5×
- Health Professions 1.2×
- Pharmacology, Toxicology and Pharmaceutics 0.7×
- Economics, Econometrics and Finance 0.6×
- Social Sciences 0.5×
- Arts and Humanities 0.5×
- Agricultural and Biological Sciences 0.3×
- Business, Management and Accounting 0.2×
- Mathematics 0.1×
- Decision Sciences 0.1×
- Computer Science 0.1×
- Materials Science 0.1×
- Engineering 0.0×
- Environmental Science 0.0×
Who are the top researchers at Start Treatment & Recovery Centers?
Ranked on the composite score, Tooru Nemoto and Lawrence S. Brown lead among researchers whose main affiliation is Start Treatment & Recovery Centers.
- 1 Tooru Nemoto United States · #304,076 worldwide 120 citations · 18 works
- 2 Lawrence S. Brown United States · #1,254,846 worldwide 16 citations · 16 works
Which keywords describe research at Start Treatment & Recovery Centers?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Breast Cancer, Tumor Microenvironment, Targeted Therapy, Resilience, Metastatic Breast Cancer and Immune Checkpoint Blockade.
- Trastuzumab
- Molecular Subtypes
- HER2
- Depression
- Precision Medicine
- Cancer Therapy
- Therapeutic Antibodies
- Public Health
- Fc Receptors
- Monoclonal Antibodies
- Tumor Regression
- Parenting Stress
- Immune Checkpoint Blockade
- Caregiver Well-Being
- Mental Health
- Resilience
- Tumor Microenvironment
- Breast Cancer
- Chemotherapy
- Immunotherapy
- Epidemiology
- Targeted Therapy
- Metastatic Breast Cancer
- Coping Strategies
- PD-1 and PD-L1
- Cancer Immunotherapy
- Clinical Trials
- Cancer
- Glycosylation
- Quality of Life
- CDK4/6 Inhibitors
- Palbociclib
- Trauma
- Metastatic
- Lymphoma
- PET Imaging
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 36 words, with their numbers
- Chemotherapy4▲ 13×10 topics
- Breast Cancer3▲ 34×5 topics
- Immunotherapy3▲ 12×11 topics
- Tumor Microenvironment3▲ 16×7 topics
- Epidemiology2▲ 1.45×12 topics
- Resilience2▲ 12×4 topics
- Targeted Therapy2▲ 27×5 topics
- Mental Health2▲ 3.7×9 topics
- Metastatic Breast Cancer2▲ 88×2 topics
- Caregiver Well-Being2▲ 83×1 topic
- Coping Strategies2▲ 18×2 topics
- Immune Checkpoint Blockade2▲ 41×1 topic
- PD-1 and PD-L12▲ 41×1 topic
- Parenting Stress2▲ 63×1 topic
- Cancer Immunotherapy2▲ 28×3 topics
- Tumor Regression2▲ 37×2 topics
- Clinical Trials2▲ 6.0×5 topics
- Monoclonal Antibodies2▲ 45×2 topics
- Cancer1▲ 2.7×15 topics
- Fc Receptors1▲ 67×1 topic
- Glycosylation1▲ 34×2 topics
- Public Health1▲ 2.5×5 topics
- Quality of Life1▲ 2.5×7 topics
- Therapeutic Antibodies1▲ 53×1 topic
- CDK4/6 Inhibitors1▲ 134×1 topic
- Cancer Therapy1▲ 6.1×10 topics
- Palbociclib1▲ 134×1 topic
- Precision Medicine1▲ 7.6×4 topics
- Trauma1▲ 16×3 topics
- Depression1▲ 3.7×6 topics
- Metastatic1▲ 49×2 topics
- HER21▲ 102×1 topic
- Lymphoma1▲ 18×2 topics
- Molecular Subtypes1▲ 36×2 topics
- PET Imaging1▲ 17×4 topics
- Trastuzumab1▲ 64×1 topic
Which research topics does Start Treatment & Recovery Centers publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Family and Disability Support Research, Monoclonal and Polyclonal Antibodies Research and Advanced Breast Cancer Therapies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 2 Family and Disability Support Research Clinical Psychology 2 works
- 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
- 5 HER2/EGFR in Cancer Research Oncology 1 works
- 6 CAR-T cell therapy research Oncology 1 works
- 7 Colorectal Cancer Treatments and Studies Oncology 1 works
- 8 Cancer Genomics and Diagnostics Cancer Research 1 works
- 9 Telemedicine and Telehealth Implementation Public Health, Environmental and Occupational Health 1 works
- 10 Migration, Health and Trauma Clinical Psychology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Start Treatment & Recovery Centers's research output changed?
Output in 2018–2022 was 26% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in New York
- Columbia University
- New York University
- Icahn School of Medicine at Mount Sinai
- Memorial Sloan Kettering Cancer Center
- City University of New York
- Human Growth Foundation
- Columbia University Irving Medical Center
- Rockefeller University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.